Harmony Biosciences Holdings, Inc. (HRMY) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
HRMY currently has 57.8M outstanding shares. with limited dilution risk as only 410K additional shares (0.7%) are authorized for issuance. The company has minimally diluted shareholders by 1.78% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 57.8M shares outstanding |
58M | 410K |
| Nov 04, 2025 |
10-Q filing | 57.6M shares outstanding |
58M | 410K |
| May 06, 2025 |
10-Q filing | 57.3M shares outstanding |
57M | 410K |
| Feb 25, 2025 |
10-K filing | 56.9M shares outstanding |
57M | 410K |
| Nov 01, 2024 |
8-K filing: On November 1, 2024, certain shareholders of Harmony Biosciences Holdings, Inc. sold 8,000,000 shares of the Company's common stock in a registered public offering. The selling shareholders also granted the underwriter an option to purchase up to 1,200,000 additional shares of common stock. |
57M | 410K |
| Oct 29, 2024 |
10-Q filing | 56.9M shares outstanding |
57M | 410K |
| Aug 06, 2024 |
10-Q filing | 56.8M shares outstanding |
57M | 410K |
| Apr 30, 2024 |
10-Q filing | 56.8M shares outstanding |
57M | 410K |
| Feb 22, 2024 |
10-K filing | 59.5M shares outstanding |
59M | 410K |
| Oct 31, 2023 |
10-Q filing | 59.9M shares outstanding |
60M | 410K |
| Aug 01, 2023 |
10-Q filing | 60.0M shares outstanding |
60M | 410K |
| May 02, 2023 |
10-Q filing | 59.7M shares outstanding |
60M | 410K |
| Feb 21, 2023 |
10-K filing | 59.2M shares outstanding |
59M | 410K |
| Nov 01, 2022 |
10-Q filing | 59.2M shares outstanding |
59M | 410K |
| Aug 02, 2022 |
10-Q filing | 59.1M shares outstanding |
59M | 410K |
| May 03, 2022 |
10-Q filing | 58.9M shares outstanding |
59M | 410K |
| Feb 28, 2022 |
10-K filing | 59.2M shares outstanding |
59M | 410K |
| Nov 09, 2021 |
10-Q filing | 57.7M shares outstanding |
58M | 410K |
| Aug 10, 2021 |
10-Q filing | 56.9M shares outstanding |
57M | 410K |
| May 11, 2021 |
10-Q filing | 56.9M shares outstanding |
57M | 410K |
| Mar 25, 2021 |
10-K filing | 56.9M shares outstanding |
57M | 410K |
| Nov 12, 2020 |
10-Q filing | 56.9M shares outstanding |
57M | 410K |
| Aug 13, 2020 |
S-1/A filing: This S-1/A filing from 2020-08-13 discusses the terms of a proposed IPO, including the assumed initial public offering price of $21.50 per share and the potential impact of price changes on the total consideration. It also details various shares of common stock issuable upon exercise of outstanding stock options and warrants. |
N/A | 410K |
| Aug 11, 2020 |
S-1/A filing: This is an S-1/A filing for an IPO with an assumed initial public offering price of $21.50 per share. |
N/A | 410K |
| Aug 06, 2020 |
S-1/A filing: This S-1/A filing outlines the terms and conditions related to the issuance of common stock, options, and convertible securities, including adjustments to preferred stock conversion prices and procedures for mandatory conversion and redemption. |
N/A | 35M |
| Jul 27, 2020 |
S-1 filing: This is an S-1 filing, which includes information about common stock, options, and convertible securities issued under various circumstances, as well as information about preferred stock conversion prices and mandatory conversion events. |
N/A | 35M |